Meeting News CoverageFrom OSN Europe

Zeiss receives CE mark for PLEX Elite 9000 swept-source OCT system

SEATTLE — The Zeiss PLEX Elite 9000, a novel swept-source optical coherence tomography platform, has received CE mark approval in the European Union, Carl Zeiss Meditec announced in a press release.

By providing fast, dense, wide and deep OCT and OCT angiography imaging, the platform “expands researchers’ ability to examine the critical retinal microstructures and microvasculature of the eye at any depth of interest (eg, vitreous, retina and choroid),” according to the release.

The PLEX Elite 9000 system is the centerpiece of the Advanced Retina Imaging network being introduced at the Association for Research in Vision and Ophthalmology meeting.

“The Advanced Retinal Imaging Network is a platform to understand swept-source OCT,” Angelo Rago, senior vice president of innovation and operations said to reporters at a press event here. “The intent is to allow researchers to drive innovation with Zeiss supporting the researchers.”

“Collaboration with leading experts has been and continues to be at the heart of our innovation process. The Advanced Retina Imaging network brings collaboration to a level not seen before and has the potential to open new frontiers of discovery in research, and to accelerate the development of innovations to benefit patients today and in the future,” Ludwin Monz, PhD, President and CEO of Carl Zeiss Meditec, said in the release.

SEATTLE — The Zeiss PLEX Elite 9000, a novel swept-source optical coherence tomography platform, has received CE mark approval in the European Union, Carl Zeiss Meditec announced in a press release.

By providing fast, dense, wide and deep OCT and OCT angiography imaging, the platform “expands researchers’ ability to examine the critical retinal microstructures and microvasculature of the eye at any depth of interest (eg, vitreous, retina and choroid),” according to the release.

The PLEX Elite 9000 system is the centerpiece of the Advanced Retina Imaging network being introduced at the Association for Research in Vision and Ophthalmology meeting.

“The Advanced Retinal Imaging Network is a platform to understand swept-source OCT,” Angelo Rago, senior vice president of innovation and operations said to reporters at a press event here. “The intent is to allow researchers to drive innovation with Zeiss supporting the researchers.”

“Collaboration with leading experts has been and continues to be at the heart of our innovation process. The Advanced Retina Imaging network brings collaboration to a level not seen before and has the potential to open new frontiers of discovery in research, and to accelerate the development of innovations to benefit patients today and in the future,” Ludwin Monz, PhD, President and CEO of Carl Zeiss Meditec, said in the release.

    See more from Association for Research in Vision and Ophthalmology